Citations

Clear

5 citation(s) found for "Deng, Yanhong".

Rethinking the Diagnosis and Management of Antibody‐Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group Recommendations
Sapir‐Pichhadze, Ruth , Cornell, Lynn D. , Dadhania, Darshana M. , Vries, Aiko P. J. de , Schinstock, Carrie A. , Carroll, Robert , Abdelrehim, Ahmad, Gan, Geliang, Deng, Yanhong , Alasfar, Sami , Bagnasco, Serena M. , Groningen, Marian C. Clahsen‐van , Kung, Vanderlene L. , Lower, Fritz, Seija, Mariana , Kraus, Edward S., Bow, Laurine M., Group, the Banff Antibody‐Mediated Injury Working, Dadhania, Darshana M , Schinstock, Carrie , Carroll, Robert P , Clahsen-van Groningen, Marian C , Cornell, Lynn , de Vries, Aiko P J , Askar, Medhat , Cooper, Matthew , Cozzi, Emanuele , Diekmann, Fritz , Gan, Geliang, Batal, Ibrahim , Budde, Klemens , Naesens, Maarten , Group, the Banff Antibody‐Mediated Injury Working

Mayo Clinic

Clinical Transplantation | April 28, 2025 | Volume: 39 | Issue: 5 | Pages: No page available

10.1111/ctr.70167 | PMID 40294134 Get It

ABSTRACTIntroductionThe diagnosis of antibody‐mediated rejection (AMR) requires input from several transplant professionals. Bringing clinical and laboratory experts together may help standardize care. Yet, little is known about current global practices of multidisciplinary meetings for AMR management.MethodsThe Banff Antibody‐Mediated Injury Working Group approached professional societies worldwide to distribute a survey on the availability, content, participants, perceived value, and barriers to the implementation of multidisciplinary meetings.ResultsFour hundred two transplant professionals from six continents caring for kidney (90.55%), liver (21.14%), pancreas (20.65%), heart (15.17%), and lung (14.18%) transplant recipients participated in the survey, and 302 (75.12%) reported attending multidisciplinary meetings. Multidisciplinary meetings were more prevalent in academic centers, in high‐ versus low‐to‐middle‐income regions (81.03% and 65.99%, respectively; p < 0.001), and in mid‐to‐large size transplant programs compared to smaller programs. Perceived value included continued professional development (97.68%) and trainee education (95.70%). AMR was reported to be discussed at these meetings by 217 respondents with case presentations reviewing patient characteristics, histology, and HLA antibody data. A third of the respondents reviewed non‐HLA/pathogenic autoantibodies and/or molecular diagnostics, with the latter being more frequently applied in high‐ versus low‐to‐middle‐income regions (46.71% and 12.31%, respectively; p < 0.001). AMR case presentations allowed diagnosis revision, actionable management plans and were perceived as improving care. The primary barrier to the implementation of multidisciplinary meetings (63.27%) was the unavailability of transplant professionals (e.g., transplant immunologists).ConclusionFacilitating multidisciplinary meetings through the remote participation of pertinent experts and incentivizing participation through remuneration, protected time, or continued medical education may help standardize AMR diagnosis and harmonize its management.
CLO24-088: Efficacy of Fruquintinib in Less Heavily Pretreated Patients (Pts) With Metastatic Colorectal Cancer (mCRC): Profile-Matched Data From FRESCO and FRESCO-2
Jones, Jeremy , Shen, Lin , Bai, Yuxian , Deng, Yanhong , Yang, Zhao, Schelman, William R., Qin, Shukui , Jones, Jeremy C , Dasari, Arvind , Eng, Cathy , Lonardi, Sara , García‐Carbonero, Rocio , Masuishi, Toshiki , Cremolini, Chiara , Ghiringhelli, François , Hubbard, Joleen M. , Bekaii‐Saab, Tanios , Xu, Rui‐Hua , Xu, Jianming , Yuan, Ying , Wei, Wei , Lin, Jianchang , Chen, Lucy L , Li, Jin

Mayo Clinic

Journal of the National Comprehensive Cancer Network | April 5, 2024 | Volume: 22 | Issue: 2.5 | Pages: No page available

10.6004/jnccn.2023.7171 Get It

Depressive Symptoms and Incident Heart Failure in the Jackson Heart Study: Differential Risk Among Black Men and Women
Gaffey, Allison E. , Cavanagh, Casey E. , Rosman, Lindsey , Wang, Kaicheng , Deng, Yanhong , Sims, Mario , O’Brien, Emily C., Chamberlain, Alanna M. , Mentz, Robert J. , Glover, LáShauntá M. , Burg, Matthew M. , Glover, LáShauntá , Glover, LáShauntá M. , Chamberlain, Alanna M , Wang, Kaicheng , Mentz, Robert J , Gaffey, Allison E. , Cavanagh, Casey E. , Rosman, Lindsey , Deng, Yanhong , Sims, Mario , O’Brien, Emily C., Glover, LáShauntá M. , Burg, Matthew

Mayo Clinic

Journal of the American Heart Association | February 22, 2022 | Volume: 11 | Issue: 5 | Pages: No page available

10.1161/jaha.121.022514 | PMID 35191315 Get It

Background Associations between depression, incident heart failure (HF), and mortality are well documented in predominately White samples. Yet, there are sparse data from racial minorities, including those who are women, and depression is underrecognized and undertreated in the Black population. Thus, we examined associations between baseline depressive symptoms, incident HF, and all‐cause mortality across 10 years. Methods and Results We included Jackson Heart Study (JHS) participants with no history of HF at baseline (n=2651; 63.9% women; median age, 53 years). Cox proportional hazards models tested if the risk of incident HF or mortality differed by clinically significant depressive symptoms at baseline (Center for Epidemiological Studies–Depression scores ≥16 versus <16). Models were conducted in the full sample and by sex, with hierarchical adjustment for demographics, HF risk factors, and lifestyle factors. Overall, 538 adults (20.3%) reported high depressive symptoms (71.0% were women), and there were 181 cases of HF (cumulative incidence, 0.06%). In the unadjusted model, individuals with high depressive symptoms had a 43% greater risk of HF ( P =0.035). The association remained with demographic and HF risk factors but was attenuated by lifestyle factors. All‐cause mortality was similar regardless of depressive symptoms. By sex, the unadjusted association between depressive symptoms and HF remained for women only ( P =0.039). The fully adjusted model showed a 53% greater risk of HF for women with high depressive symptoms ( P =0.043). Conclusions Among Black adults, there were sex‐specific associations between depressive symptoms and incident HF, with greater risk among women. Sex‐specific management of depression may be needed to improve cardiovascular outcomes.
Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage
Fortune, Brett E. , García–Tsao, Guadalupe , Deng, Yanhong , Fallon, Michael B. , Sigal, Samuel H. , Chalasani, Naga , Lim, Joseph K. , Reuben, Adrian , Vargas, Hugo E. , Abrams, Gary A. , Lewis, Michele D. , Hassanein, Tarek , Trotter, James F. , Beavers, Kimberly L. , Ganger, Daniel , Thuluvath, Paul J. , Grace, Norman D., Groszmann, Roberto J., Ciarleglio, Maria , Sanyal, Arun J. , Vargas, Hugo E , Lewis, Michele D

Mayo Clinic

Journal of Clinical Gastroenterology | October 25, 2016 | Volume: 51 | Issue: 5 | Pages: 446-453

10.1097/mcg.0000000000000733 | PMID 27779613 Get It

Goals/Background: Data on acute variceal hemorrhage (AVH) in the United States is limited and the best method to stratify risk is not clear. Taking advantage of a prospective US cohort study, we aimed to (1) describe clinical outcomes of AVH and their predictors; (2) compare predictors of 6-week mortality. Study: Prospective 15-center US cohort of patients with cirrhosis presenting with endoscopically proven AVH, all of whom received antibiotics, vapreotide (a somatostain analog) infusion and endoscopic band ligation. Patients were enrolled between August 2006 and April 2008. Primary outcome was 6-week mortality. Secondary outcome was 5-day treatment failure. The prognostic value of Child-Turcotte-Pugh (CTP) class, Model for End-stage Liver Disease (MELD) score and a recent recalibrated MELD were compared. Results: Seventy eligible patient were enrolled; 18 (26%) patients died within 6-weeks of index bleed. Demographic, clinical, and laboratory data were compared between survivors and nonsurvivors. Multivariate models showed that admission CTP or the MELD score (separately) were independent predictors of survival. The discriminative values of CTP (area under receiver operating characteristic: 0.75) and MELD (area under receiver operating characteristic: 0.79) were good and not significantly different (P=0.27). However, calibration (correlation between observed and predicted mortality) test was significantly better for CTP than for MELD, with the recently described recalibrated MELD model having the worst agreement. Predicted mortality for CTP-A was <10%, CTP-B 10% to 30%; and CTP-C >33%. Conclusions: AVH mortality of 26% in the United States is in the upper range limit compared with recent series but may be due to inclusion of patients with more advanced cirrhosis. CTP score has the best overall performance in the prediction of 6-week mortality and is best at stratifying risk.
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis
Assis, David N. , Abdelghany, Osama, Cai, Shi‐Ying , Gossard, Andrea A., Eaton, John E. , Keach, Jill C., Deng, Yanhong , Setchell, Kenneth D.R. , Ciarleglio, Maria , Lindor, Keith D. , Boyer, James L.

Mayo Clinic

Journal of Clinical Gastroenterology | July 16, 2016 | Volume: 51 | Issue: 2 | Pages: e11-e16

10.1097/mcg.0000000000000591 | PMID 27428727 Get It

Goals: To perform an exploratory pilot study of all-trans retinoic acid (ATRA) combined with ursodeoxycholic acid (UDCA) in patients with primary sclerosing cholangitis (PSC). Background: PSC is a progressive disorder for which there is no accepted therapy. Studies in human hepatocyte cultures and in animal models of cholestasis indicate that ATRA might have beneficial effects in cholestatic disorders. Study: ATRA (45 mg/m2/d, divided and given twice daily) was combined with moderate-dose UDCA in patients with PSC who had incomplete response to UDCA monotherapy. The combination was administered for 12 weeks, followed by a 12-week washout in which patients returned to UDCA monotherapy. We measured alkaline phosphatase (ALP), alanine aminotransferase (ALT), bilirubin, cholesterol, bile acids, and the bile acid intermediate 7α-hydroxy-4-cholesten-3-one (C4) at baseline, week 12, and after washout. Results: Fifteen patients completed 12 weeks of therapy. The addition of ATRA to UDCA reduced the median serum ALP levels (277±211 to 243±225 U/L, P=0.09) although this, the primary endpoint, did not reach significance. In contrast, median serum ALT (76±55 to 46±32 U/L, P=0.001) and C4 (9.8±19 to 7.9±11 ng/mL, P=0.03) levels significantly decreased. After washout, ALP and C4 levels nonsignificantly increased, whereas ALT levels significantly increased (46±32 to 74±74, P=0.0006), returning to baseline. Conclusions: In this human pilot study, the combination of ATRA and UDCA did not achieve the primary endpoint (ALP); however, it significantly reduced ALT and the bile acid intermediate C4. ATRA appears to inhibit bile acid synthesis and reduce markers of inflammation, making it a potential candidate for further study in PSC (NCT 01456468).